Psychiatric effects of neuropharmacological agents.
Department of Psychiatry, University of Washington, Seattle, WA, USA.
Jesse R
JR
Fann
D001007:Anxiety / Q000188:drug therapy / Q000523:psychology; D001714:Bipolar Disorder / Q000188:drug therapy / Q000523:psychology; D001932:Brain Neoplasms / Q000150:complications / Q000523:psychology; D003072:Cognition Disorders / Q000188:drug therapy / Q000523:psychology; D003693:Delirium / Q000188:drug therapy / Q000523:psychology; D003866:Depressive Disorder / Q000188:drug therapy / Q000523:psychology; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy* / Q000523:psychology; D008875:Middle Aged; D018697:Nootropic Agents / Q000627:therapeutic use*; D011595:Psychomotor Agitation / Q000188:drug therapy / Q000523:psychology; D011618:Psychotic Disorders / Q000188:drug therapy / Q000523:psychology
D018697:Nootropic Agents